Claim Missing Document
Check
Articles

Found 3 Documents
Search

Antibacterial Test Of Avocado Leaf Ethanol Extract (Persea americana Mill) On Propionibacterium Acne Rosanto Tamba; Harsan Arifin Kasan; Ika Suryani Pangaribuan
International Journal of Health Engineering and Technology Vol. 3 No. 2 (2024): IJHET JULY 2024
Publisher : CV. AFDIFAL MAJU BERKAH

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55227/ijhet.v3i2.219

Abstract

Avocado leaves are one plant that can be used as an antibacterial. The chemical content of flavonoids, alkaloids, tannins and saponins has the potential to inhibit bacterial growth. This research aims to determine the antibacterial activity of ethanol extract of avocado leaves against Staphylococcus aureus bacteria. This research uses laboratory experiments using samples of avocado leaf extract (Persea americana Mill). With concentrations of 20%, 40%, 60% and 80% using the diffusion method. The ability of avocado leaf extract to inhibit Staphylococcus aureus bacteria can be seen from the size of the inhibition zone, namely positive by looking at the area of the inhibition zone around the disc using a caliper.  This research shows that the diameter of the inhibition zone for Staphylococcus aureus at a concentration of 20% has an inhibition zone diameter of 8.71 mm, namely the medium category, a concentration of 40% has an inhibition zone diameter of 10.33 mm, namely the strong category, a concentration of 60% has an inhibition zone diameter. of 12,66 mm, namely the strong category, a concentration of 80% has an inhibitory zone diameter of 15,61 mm, namely the strong category. Based on the research results, it can be concluded that the ethanol extract of avocado leaves has activity to inhibit propionibacterium acne bacteria.
Description of Polypharmacy and Interactions that can Reduce the Effectiveness of Dyspepsia Drugs in patient BPJS with Dyspepsia at the Porsea Regional General Hospital based on Prescriptions Period November-January 2020 Meliani Dwi Lestari; Rosanto Tamba; Melati Silaban
International Journal of Health Engineering and Technology Vol. 1 No. 5 (2023): IJHET - JANUARY 2023
Publisher : CV. AFDIFAL MAJU BERKAH

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (526.848 KB) | DOI: 10.55227/ijhet.v1i5.96

Abstract

Dyspepsia is a collection of symptoms of pain, persistent or recurring discomfort in the upper abdomen, feeling full when eating, feeling full quickly, bloating, belching, decreased appetite, nausea, vomiting. Dyspepsia ranks 5th out of the top 10 diseases in hospitalized patients and 6th for outpatients. The prevalence of dyspepsia varies between 7-45%, depending on the definition used in geographic location. The prevalence in Asia is around 8-30%. It is estimated that 30% of patients who come to the gastroenterologist's practice are 60% with complaints of dyspepsia, around 20-40% of adults experience dyspepsia, whereas in general clinics it is only 2-5%. This study aims to Description of Polypharmacy and Interactions that can Reduce the Effectiveness of Dyspepsia Drugs in patient BPJS with Dyspepsia at the Porsea Regional General Hospital based on Prescriptions Period November-January 2020. The research design was descriptive with a retrospective time approach carried out at Porsea Hospital, Toba Regency, based on prescriptions for the period November-Januari 2020, data were collected in February 2020 with a sample of 118 cases using the Simple random sampling technique (November: 41 cases, December: 38 cases, January 39 cases). The instrument used to collect data in this study is the data collection format. The results showed polypharmacy in outpatient BPJS patients with dyspepsia at the Porsea Regional General Hospital for the period November-January 2020, namely 71 (60.17%) cases with major polypharmacy (5-11) and 47 (39.83%) cases with minor polypharmacy. For future researchers to examine the effects of the use of polypharmacy on reducing the effectiveness of dyspepsia drugs with guide books or other references.
Use Of Drugs And Polypharmacy In Dyspepsia Patients At UPT. Narumonda Health Center Andi Josep Nicolas Hutahaean; Heny Kuriasari; Rosanto Tamba; Chrisfani Aritonang
International Journal of Health Engineering and Technology Vol. 2 No. 4 (2023): IJHET NOVEMBER 2023
Publisher : CV. AFDIFAL MAJU BERKAH

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55227/ijhet.v2i4.176

Abstract

Changes in lifestyle and eating patterns are one of the causes of digestive tract disorders. The most common digestive disorder suffered is dyspepsia. Dyspepsia is a group of clinical symptoms or syndromes consisting of pain, bloating, heat and discomfort in the stomach top. This study aims to determine the description of drug use and polypharmacy in dyspepsia patients at UPT. Narumonda Health Center for the January-April 2023 period based on drug class, type of drug, other types of drug and polypharmacy. This research is a descriptive study with a retrospective approach carried out in June 2023, data obtained from the Patient Visit Book at UPT. Narumonda Community Health Center using total sampling method. The data obtained is presented in the form of frequency tables and diagrams. The research results showed that there were 73 patients from January-April 2023. Based on the antacid drug class (antacid) 73.97%, proton pump inhibitor (Lansoprazole) 63.51%, prokinetic (domperidone) 18.92%, H2 receptor antagonist group (Cetirizine) 61.54%. Based on other drugs, the most widely used is the analgesic group (paracetamol) 36.99%. Minor group polypharmacy 91.89%, major group 8.11%.